Clinical Trial of PCV24 in Adults Aged ≥18 Years

NCT07543198 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infectious Disease

Interventions

BIOLOGICAL: Sinovac Low-dosage PCV24
BIOLOGICAL: Sinovac Middle-dosage PCV24
BIOLOGICAL: Sinovac High-dosage PCV24
BIOLOGICAL: Pneumovax®

Sponsor

Sinovac Life Sciences Co., Ltd.